Find uplifting stories about heroes, innovations, and solutions
6875 results for "car t cells"
Scientists have discovered that a cancer treatment called CAR T-cell therapy can stop autoimmune diseases like lupus and multiple sclerosis without the dangerous side effects. Hundreds of patients are already experiencing remarkable recoveries, and the first treatments could be approved next year.
Jurassic Park star Sam Neill has announced he's cancer-free after a groundbreaking CAR T-cell therapy trial eliminated his aggressive blood cancer. The 78-year-old actor is now championing broader access to the revolutionary treatment that saved his life when traditional chemotherapy failed.
Actor Sam Neill is cancer-free after a groundbreaking treatment that turns the body's own immune cells into cancer-fighting superweapons. Scientists say we've only scratched the surface of what's possible.
Actor Sam Neill announced he has no cancer in his body, four years after his stage three lymphoma diagnosis nearly ended his life. The Jurassic Park star credits an innovative therapy that genetically modifies blood cells to attack cancer.
Cancer specialists just published the first comprehensive guide to help patients thrive years after groundbreaking CAR-T cell therapy. The new roadmap tackles a crucial gap as more blood cancer patients survive longer than ever before.
A groundbreaking cell therapy has successfully treated stiff person syndrome, a rare neurological disorder that causes severe muscle stiffness and mobility problems. If approved by the FDA this summer, it would become the first treatment for the condition and the first personalized CAR-T therapy for any autoimmune disease.
China has approved the world's first CAR-T cell therapy designed to treat solid tumors, breaking through a barrier that has stumped cancer researchers for decades. The treatment offers new hope for thousands of advanced gastric cancer patients who have run out of options.
Scientists are repurposing a powerful cancer treatment to "reset" the immune systems of people with severe autoimmune diseases, and early results show patients going into complete remission. This breakthrough could transform treatment for millions living with conditions like lupus and multiple sclerosis.
China just approved the first CAR T-cell therapy ever designed to treat solid tumors, offering new hope to advanced gastric cancer patients who've run out of options. This breakthrough could reshape how doctors treat stomach, pancreatic, and other difficult cancers.
Researchers at Memorial Sloan Kettering developed a groundbreaking CAR T cell therapy that targets leukemia while sparing healthy blood cells. The innovation came from studying patients whose cancer went into long-term remission.
Mount Sinai researchers discovered that focused radiation helps CAR-T therapy work better against tough-to-treat solid tumors like lung cancer and melanoma. The breakthrough could make this life-saving treatment safer and more effective for thousands of cancer patients.
Scientists have found a way to use CAR T-cells, already proven to cure some cancers, to slow the devastating effects of ALS by targeting rogue immune cells in the brain. The breakthrough could extend lives and eventually help treat dementia and other neurodegenerative diseases.
Scientists discovered that making cancer cells physically stiffer dramatically improved CAR T-cell therapy results in mice with severe skin cancer. This breakthrough could help save more lives by making one of medicine's most promising cancer treatments even more effective.
Researchers have solved a major puzzle in cancer treatment by learning how to grow helper T cells from stem cells for the first time. The breakthrough could make powerful cancer therapies cheaper and available to millions more patients.
A German woman who spent weeks bedridden with three life-threatening autoimmune diseases is now symptom-free after a single treatment with engineered immune cells. She hasn't needed medication since receiving the therapy that doctors called her "last chance."
Two patients who spent years waiting for kidney transplants with nearly zero chance of finding a match just received new organs thanks to cancer-fighting cells repurposed for transplant medicine. The breakthrough could help 5,000 highly sensitized Americans waiting for kidneys.
Twenty people with smoldering multiple myeloma have zero detectable cancer cells after receiving an aggressive immunotherapy treatment. The results are so complete that researchers are cautiously using a word they usually avoid: cure.
A breakthrough "off-the-shelf" CAR-T therapy eliminated residual cancer cells three times more effectively than standard care in lymphoma patients. The treatment could prevent cancer recurrence in high-risk patients for the first time.
The FDA just granted breakthrough status to a promising new CAR T-cell therapy designed to fight aggressive blood cancers. This designation could speed up access to a treatment that harnesses the immune system's power to target previously hard-to-treat malignancies.
A new stem cell transplant developed at Johns Hopkins has cured sickle cell disease in 95% of patients, using half-matched donors like parents or siblings. The breakthrough means nearly every sickle cell patient can now access a cure that also preserves fertility.
Showing 20 of 6875